Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

EGAS00001002692-sc-2019-09-05T14:59:52Z - samples

ABSTRACT: This study investigates the genomic and transcriptomic characteristics of Wilm's tumour organoids . This dataset contains all the data available for this study on 2019-09-05.

PROVIDER: EGAD00001005312 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

EGAS00001003094-sc-2019-09-05T14:59:59Z - samples

Project description:Swift kit whole genome bisulphite of MPN colonies . This dataset contains all the data available for this study on 2019-09-05.

| EGAD00001005313 | EGA

Wilms Tumour organoid sequencing WGS

Project description:This study investigates the genomic and transcriptomic characteristics of Wilm's tumour organoids

| EGAS00001002692 | EGA

Proteomics of groundwater microbiomes collected from five wells in Alberta, Canada

Project description:Groundwater samples were collected from five wells in Alberta, Canada. The sampling location and time are indicated in the table below. 13 to 29 genomes were assembled from each metagenome. Proteomic analyses were performed to investigate which genomes and genes were expressed in each well. Sample ID Location Latitude (NAD 83) Longitude (NAD 83) Sampling date 19GWC19026 218 Cluny 50.85 -112.84 30/07/2019 19GWC19028 114 Ross Creek 49.99 -110.46 31/07/2019 19GWC19045 265 Metiskow 52.42 -110.61 18/09/2019 19GWE00050 991 Cynthia 56.22 -117.81 04/09/2019 19GWE00515 33 Fort McMurray 56.98 -111.85 17/09/2019

2024-05-21 | PXD044305 | Pride

Evaluation of Data Analysis Platforms and Compatibility with MALDI-TOF Imaging Mass Spectrometry Data Sets

Project description:Within this MassIVE submission is six IMS datasets used in this publication. 1. WT PA14 IMS at 500 um (2018-01-12) 2. WT PA14 IMS at 500 um (2019-05-06) 3. WT PA14 IMS at 500 um (2016-06-09) 4. WT PA14 IMS at 200 um (2017-09-21) 5. WT PA14 half colony IMS at 500 um (2017-05-08) 6. phz knockout PA14 grown in light or dark conditions at 300 um (2018-08-08)

2020-05-06 | MSV000085381 | MassIVE

Transcriptional profiling of mouse CRL-2019 cell line of MH-S cells treated with recombinant PVL versus untreated.

Project description:cDNA microarray of the cellline MH-S cells (ATCC: CRL-2019) that were treated with recombinant PVL (rPVL) versus untreated cells

2010-12-21 | E-MEXP-2513 | biostudies-arrayexpress

The peptide repertoire of HLA-B27 includes ligands with lysine at P2 anchor position

Project description:The HLA-B*27 peptidome has drawn significant attention due to the genetic association between some of the HLA-B*27 alleles and the inflammatory rheumatic disease ankylosing spondylitis (AS). The role of HLA-B*27 in this condition is not known yet. This study aims to expand the known limits of the HLA-B*27 peptidome in order to facilitate selection and testing of new peptides, possibly implicated with the disease. The HLA peptidomes of HeLa and C1R cell lines stably transfected with the AS-associated HLA-B*27:05 allele, the non-associated HLA-B*27:09 allele, or their mutants with Cysteine 67 replaced by Serine (C67S), were analyzed on a very large scale. In addition, the peptidomes of HLA-B*27:05 and HLA-B*27:05-C67S were analyzed from transgenic rats’ spleens. The results indicate that a fraction of HLA-B*27 peptides contain lysine at their second position (P2), in addition to the more commonly found peptides with arginine, or the less common glutamine located at this anchor position. Furthermore, the C67S mutation increases the percentages of peptides with glutamine or lysine at their P2 position, in both HLA-B*27:05 and HLA-B*27:09. Therefore, peptides with P2 lysine should be considered as valid ligands of HLA-B*27 molecules and taken into account while looking for candidate for arithrogenic peptides.

2018-04-10 | PXD007756 | Pride